Hundreds of organoids may be generated from fresh tissue to provide a reasonable approximation of tumour heterogeneity.10 Pools generated from PD-L1-positive patients containing both PD-L1-positive and negative organoids responded to nivolumab with a significant dose-dependent size reduction within 24 h. This evidence concerns the gene CD274 and neoplasm.